Valemetostat is under clinical development by Daiichi Sankyo and currently in Phase I for Metastatic Renal Cell Carcinoma.

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC ...

Investigators sought to determine the safety and accuracy of remote cutaneous confocal microscopy vs histopathological diagnosis of melanoma and keratinocyte carcinoma.